Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04180930 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 23, 2025 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: May 2024 to Jun 30, 2025
    • Site contacts updated at 1 of 3 sites
    v6
  2. Site contacts updated at 1 of 3 sitesv5
  3. Primary and study completion dates: Jun 2022 to May 2024
    • Study sites: 2 to 3
    v4
  4. Re-verified, no change to tracked fieldsv3
  5. Site details revised at 1 of 2 sitesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new PTSD assessments, the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (PSSI-5) and compare the results between the two new assessments and the previous "gold standard", the Clinician Administered PTSD Scale for DSM-IV (CAPS-IV). Biomarkers believed to be related to PTSD (e.g., biofluid biomarkers, cognitive and physiological markers, and neural activity as measured by EEG) will be collected to inform targeted interventions in specific groups of patients and other large-scale biomarker discovery efforts in the field. Participants will be 950 male and female active duty military and veterans ages 18 or older who have been exposed to at least one traumatic event.
Trial Details
NCT Number NCT04180930
Lead Sponsor U.S. Army Medical Research and Development Command
Conditions
(from sponsor)		 Stress Disorders, Post-Traumatic
Related terms Stress Disorders, Post-Traumatic
Enrollment 950 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov